Amplia Therapeutics Limited (ASX:ATX)
Australia · Delayed Price · Currency is AUD 0.0820
+0.0010 (1.23%)
Oct 22, 2026, 10:30 AM AEDT
Amplia Therapeutics Market Cap
Amplia Therapeutics has a market cap or net worth of 42.09 million as of October 21, 2026. It is the 34,393rd most valuable company in the world and the 855th biggest in Australia. Its market cap has decreased by 43.42% in one year.
Market Cap
42.09M
Enterprise Value
14.58M
Revenue
4.79M
Global Rank
Country Rank
#855 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since December 23, 2013, Amplia Therapeutics's market cap has increased from 34.50M to 42.09M, an increase of 22.02%. That is a compound annual growth rate of 1.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 42.09M | -45.31% |
| Dec 31, 2025 | 76.96M | 122.90% |
| Dec 31, 2024 | 34.53M | 122.47% |
| Dec 28, 2023 | 15.52M | - |
| Dec 29, 2022 | 15.52M | -51.48% |
| Dec 31, 2021 | 31.99M | 24.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Prescient Therapeutics | 66.34M |
| Neurizon Therapeutics | 62.01M |
| Alterity Therapeutics | 61.86M |
| Arovella Therapeutics | 60.44M |
| Avecho Biotechnology | 54.09M |
| Entropy Neurodynamics | 53.91M |
| Immutep | 33.90M |
| Botanix Pharmaceuticals | 32.84M |